Delivery Order SPE2DB22D3501-SPE2DB25FVU02

Award Date 5/22/25
Potential Completion Date 5/23/25
Potential Value $3.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ferumoxytol 510 mg/17 ml vial, a medical product. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,655.48 and a performance period ending on June 11, 2025. The contract is not a set-aside award, indicating open competition. AmerisourceBergen Drug Corp also...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 510 mg/17 mL vials of the drug Ferumoxytol, with a ceiling value of $4,032.21 and a period of performance through May 28, 2025. The contract is a firm fixed price arrangement and is not set aside for any socioeconomic program. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 510 mg/17 ml vials of the pharmaceutical drug ferumoxytol, valued at $6,484.80. The contract has an ultimate completion date of April 9, 2025 and is a firm fixed price delivery order. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is for the delivery of Ferumoxytol, a 510 mg/17 ml vial pharmaceutical product, awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award has a ceiling value of $3,267.51 and an ultimate completion date of January 24, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug...
This federal contract award is for the delivery of Ferumoxytol, a 510 mg/17 ml vial, to the Defense Logistics Agency (DLA). The $3,724.60 firm fixed price Delivery Order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of December 11, 2024 and was awarded on December 10, 2024. The contract is not designated with a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
This federal contract award, valued at $2,161.60, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ferumoxytol 510 mg/17 ml vial, a pharmaceutical product, with a performance period extending to April 2025. The contract is a Firm Fixed Price Delivery Order, which is part of a larger Indefinite Delivery Contract (IDC) vehicle, designated as SPE2DX, held by...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,405.44, is a Firm Fixed Price delivery order for the supply of 4567887605 - FERUMOXYTOL 510 MG/17 ML VIAL 17ML. The contract has an ultimate completion date of April 14, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is for the delivery of ferumoxytol, a 510 mg/17 ml vial of pharmaceutical medication, to the Defense Logistics Agency (DLA). The $1,630.03 fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on December 3, 2024. The contract has an ultimate completion date of December 4, 2024 and was not set aside for any specific type of business. AmerisourceBergen holds a significant $999,999,999...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ferumoxytol 510 mg/17 ml vials, a medical product used for the treatment of iron deficiency anemia. The contract has a ceiling value of $2,398.60 and a period of performance through May 22, 2025. This contract is not designated as a set-aside. AmerisourceBergen...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,793.00, is for the delivery of FERUMOXYTOL 510 MG/17 ML VIAL 17ML, a medical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of March 24, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB25FVU02
    Delivery Order

This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of Ferumoxytol 510 mg/17 ml vials, a pharmaceutical product. The contract has a ceiling value of $3,146.04 and is a firm fixed price delivery order, with a performance period ending on May 23, 2025.

The contract is not set aside for any particular business type. Amerisourcebergen Drug Corp is a for-profit organization that holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This award is likely part of the company's broader ability to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.

Generated 8/21/25, 9:54 AM